Overview

Study Evaluating GAP-486 in Heart Rhythm

Status:
Terminated

Trial end date:
2006-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to learn the effects of a test drug on heart rhythm, and to provide additional data to see if the test drug is well tolerated and safe.

Phase:

Phase 2

Details

Lead Sponsor:

Wyeth is now a wholly owned subsidiary of Pfizer